Eltenac
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530021

CAS#: 72895-88-6

Description: Eltenac is a cyclooxygenase (COX) inhibitor potentially for the treatment of pain.


Chemical Structure

img
Eltenac
CAS# 72895-88-6

Theoretical Analysis

MedKoo Cat#: 530021
Name: Eltenac
CAS#: 72895-88-6
Chemical Formula: C12H9Cl2NO2S
Exact Mass: 300.97
Molecular Weight: 302.170
Elemental Analysis: C, 47.70; H, 3.00; Cl, 23.46; N, 4.64; O, 10.59; S, 10.61

Price and Availability

Size Price Availability Quantity
1mg USD 420 2 Weeks
5mg USD 1200 2 Weeks
Bulk inquiry

Synonym: B78820; BY820; B 78820; BY 820; B-78820; BY-820

IUPAC/Chemical Name: 4-(2,6-Dichloroanilino)-3-thiopheneacetic acid

InChi Key: AELILMBZWCGOSB-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H9Cl2NO2S/c13-8-2-1-3-9(14)12(8)15-10-6-18-5-7(10)4-11(16)17/h1-3,5-6,15H,4H2,(H,16,17)

SMILES Code: O=C(O)CC1=CSC=C1NC2=C(Cl)C=CC=C2Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 302.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Klein T, Dullweber F, Brehm C, Prinz W, Baudler M, Figala V, Herrmann M. Characterization of eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo. Biochem Pharmacol. 2008 Sep 15;76(6):717-25. doi: 10.1016/j.bcp.2008.06.025. Epub 2008 Jul 12. PMID: 18674517.


2: Ottillinger B, Gömör B, Michel BA, Pavelka K, Beck W, Elsasser U. Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage. 2001 Apr;9(3):273-80. doi: 10.1053/joca.2000.0385. PMID: 11300751.


3: Prügner W, Huber R, Lühmann R. Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects. J Vet Pharmacol Ther. 1991 Jun;14(2):193-9. doi: 10.1111/j.1365-2885.1991.tb00822.x. PMID: 1920607.


4: MacKay RJ, Daniels CA, Bleyaert HF, Bailey JE, Gillis KD, Merritt AM, Katz TL, Johnson JC, Thompson KC. Effect of eltenac in horses with induced endotoxaemia. Equine Vet J Suppl. 2000 Jun;(32):26-31. doi: 10.1111/j.2042-3306.2000.tb05330.x. PMID: 11202378.


5: Hamm D, Turchi P, Johnson JC, Lockwood PW, Thompson KC, Katz T. Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis. Am J Vet Res. 1997 Mar;58(3):298-302. PMID: 9055978.


6: Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskåhl B, Tamelander G. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol. 1997;26(4):287-92. doi: 10.3109/03009749709105318. PMID: 9310109.


7: Dyke TM, Sams RA, Thompson KG, Ashcraft SM. Pharmacokinetics of multiple-dose administration of eltenac in horses. Am J Vet Res. 1998 Nov;59(11):1447-50. PMID: 9829405.


8: Cuniberti B, Odore R, Barbero R, Cagnardi P, Badino P, Girardi C, Re G. In vitro and ex vivo pharmacodynamics of selected non-steroidal anti-inflammatory drugs in equine whole blood. Vet J. 2012 Mar;191(3):327-33. doi: 10.1016/j.tvjl.2011.03.016. Epub 2011 May 11. PMID: 21565533.


9: Häfner D, Ibrahim M, Wollin L, Germann PG. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS). Exp Toxicol Pathol. 2003 Jul;55(1):59-68. doi: 10.1078/0940-2993-00295. PMID: 12940630.


10: Goodrich LR, Furr MO, Robertson JL, Warnick LD. A toxicity study of eltenac, a nonsteroidal anti-inflammatory drug, in horses. J Vet Pharmacol Ther. 1998 Feb;21(1):24-33. doi: 10.1046/j.1365-2885.1998.00813.x. PMID: 9507454.


11: Göktaş EF, Kabil E, Arıöz F. Quantification and validation of nine nonsteroidal anti-inflammatory drugs in equine urine using gas chromatography- mass spectrometry for doping control. Drug Test Anal. 2020 Aug;12(8):1065-1077. doi: 10.1002/dta.2864. Epub 2020 Jun 28. PMID: 32449838.